Expression of CD133 and poor outcome in neuroblastoma associated with chemoresistance mediated by AKT pathway

被引：0
|
作者：
Sartelet, H.
Haddad, E.
Imbriglio, T.
Arsenault, M.
Ohta, S.
Barrette, S.
Sinnett, D.
Laverdiere, C.
Oligny, L.
Vassal, G.
机构：
[1] Hop St Justine, Montreal, PQ H3T 1C5, Canada
[2] CHU St Justine, Montreal, PQ, Canada
[3] Shiga Univ Med Sci, Otsu, Ireland
[4] Inst Gustave Roussy, Villejuif, France
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2009年 / 27卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
10007
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Expression of CD133 in Synovial Sarcoma
    Terry, Jefferson
    Nielsen, Torsten
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2010, 18 (02): : 159 - 165
  • [22] CD133 Over-Expression in Breast Cancer: A Marker of Poor Prognosis
    Joseph, C.
    Arshad, M.
    Kurozumi, S.
    Althobiti, M.
    Miligy, I. M.
    Al-izzi, S.
    Toss, M. S.
    Goh, F.
    Johnston, S. J.
    Martin, S. G.
    Ellis, I. O.
    Mongan, N. P.
    Green, A. R.
    Rakha, E. A.
    JOURNAL OF PATHOLOGY, 2019, 249 : S24 - S24
  • [23] Expression of CD133 in acute leukemia
    Tolba, Fetnat M.
    Foda, Mona E.
    Kamal, Howyda M.
    Elshabrawy, Deena A.
    MEDICAL ONCOLOGY, 2013, 30 (02)
  • [24] Analysis of stemness gene expression and CD133 abnormal methylation in neuroblastoma cell lines
    Schiapparelli, Paula
    Enguita-German, Monica
    Balbuena, Jana
    Rey, Juan A.
    Lazcoz, Paula
    Castresana, Javier S.
    ONCOLOGY REPORTS, 2010, 24 (05) : 1355 - 1362
  • [25] Expression of CD133 and nestin in sarcomas
    Veselska, R.
    Zambo, I.
    Skoda, J.
    Hermanova, M.
    Neradil, J.
    Sana, J.
    Chlapek, P.
    Zitterbart, K.
    Mudry, P.
    Hamp, A.
    Sterba, J.
    TUMOR BIOLOGY, 2012, 33 : 20 - 20
  • [26] Expression of CD133 in acute leukemia
    Fetnat M. Tolba
    Mona E. Foda
    Howyda M. kamal
    Deena A. Elshabrawy
    Medical Oncology, 2013, 30
  • [27] CD133 expression in colorectal adenomas
    Handra-Luca, Adriana
    Taconet, Sarah
    JOURNAL OF CLINICAL PATHOLOGY, 2013, 66 (12) : 1097 - 1098
  • [28] CD133+ HCC cancer stem cells confer chemoresistance by preferential expression of the Akt/PKB survival pathway
    Ma, S.
    Lee, T. K.
    Zheng, B-J
    Chan, K. W.
    Guan, X-Y
    ONCOGENE, 2008, 27 (12) : 1749 - 1758
  • [29] CD133+ HCC cancer stem cells confer chemoresistance by preferential expression of the Akt/PKB survival pathway
    S Ma
    T K Lee
    B-J Zheng
    K W Chan
    X-Y Guan
    Oncogene, 2008, 27 : 1749 - 1758
  • [30] CD133 expression in osteosarcoma and derivation of CD133+ cells
    Li, Ji
    Zhong, Xiao-Yan
    Li, Zong-Yu
    Cai, Jin-Fang
    Zou, Lin
    Li, Jian-Min
    Yang, Tao
    Liu, Wei
    MOLECULAR MEDICINE REPORTS, 2013, 7 (02) : 577 - 584
12345